PACS Group, Inc. (PACS) — closed signal from October 23, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on January 21, 2026 — +188.6% at the close.
Predicted vs. what happened
What happened
Reached its target in 25 days.
The thesis — published October 23, 2025
PACS is a risky, short-term rebound idea with leadership concerns. On 9-24, shares fell 29% after the CFO quit over policy violations. On 10-01, the NYSE gave more time to file and the company projected record first-half revenue. Price momentum is weak and a 10-09 valuation review raised flags. We will wait for clean filings and clear price strength before adding over the next 0-3 months.
Primary drivers
- CFO quit; company may fix past reports (9-24)
- NYSE gave more time; aiming for record first-half sales (10-01)
- Valuation check suggested the stock may be priced too high (10-09)
- Stock fell hard; need signs the business is stabilizing
How it played out
PACS: target reached in 25 days
Lyra published PACS on 2025-10-23 at $12.50 as a risky short-term rebound idea with 30% expected growth. The thesis pointed to leadership concerns after the CFO quit, extra NYSE time to file, projected record first-half sales, a valuation review that raised flags, weak price momentum, and the need for cleaner filings and clearer strength.
Inside the window, the stock reached the $16.25 target in 25 days. It later peaked at $43.08 on 2026-01-13, a 244.6% gain from the publication price. It ended the window at $36.07. The thesis played out, and the move went far beyond the target.
What happened during the window
On 2025-11-20, Barron's reported that PACS posted earnings for the first time in a year, with third-quarter revenue of $1.34 billion and adjusted earnings of 32 cents a share. The same article said PACS guided 2025 revenue to $5.25 billion to $5.35 billion.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.